Laser vs Drugs for Diabetic Retinopathy: Mostly a Toss-Up (CME/CE)

by MedPage Today • 2016/09/06 • 0 Comments

(MedPage Today) -- But Lucentis favored for some outcomes in randomized trial

← Allergan CEO commits to responsible drug pricing ideals

Study shows link between steroid use and poor outcomes in Lyme disease-associated facial paralysis →